Topical Treatment for Atopic Dermatitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9+
SponsorWake Forest University Health Sciences

About this trial

Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.

Eligibility criteria

Qualifiers

Diagnosis of skin dermatitis

Age > 9

Ability to return for a one-week clinical studies follow-up

Patients who are candidates for treatment with 0.1% triamcinolone ointment (even if they weren't in the study)

Disqualifiers

Patients without the diagnosis of skin dermatitis

Inability to return for a one week follow up appointment

Body Surface Area (BSA) affected <2%

Trial design

Treatments tested in this trial

  • Demonstration of applying triamcinolone cream
  • Mobile App Use
  • Standard of Care

Treatment groups

30 Participants
are divided into 3 treatment groups